In Vitro Drug Release Testing for LA Drug Products QC (16of35) Complex Generics - Sep. 25-26, 2019 

Vidula Kolhatkar, from CDER Office of Pharmaceutical Quality’s Division of Biopharmaceutics, discusses the current approach to in vitro release test (IVRT) to include product specific in vitro release test, discriminating ability, and acceptance criteria. She also shares common deficiencies and steps forward.
Learn more at www.fda.gov/dr...
_______________________________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.
Visit www.fda.gov/cd... and www.fda.gov/cd... for news and a repository of training activities.
Email: CDERSBIA@fda.hhs.gov
Phone: (301) 796-6707 I (866) 405-5367
LinkedIn: / cder-small-business-an...
Twitter: / fda_drug_info
CDER small business e-mail update subscription: updates.fda.go...